期刊文献+

前列腺癌双睾切除患者与代谢综合征关系研究 被引量:2

Association between bilateral orchidectomy and metabolic syndrome in males with prostate cancer
原文传递
导出
摘要 目的评估前列腺癌患者双睾切除术后代谢综合征患病风险。方法研究对象为100例老年男性,以美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP-ATP Ⅲ)提出的诊断代谢综合征的标准。实验组为50例因前列腺癌行双睾切除术后1年以上的患者,对照组为上海市男性健康俱乐部50名年龄匹配的男性,测身高、体重、腰围、血压、空腹血糖、血脂、血清总睾酮,计算体重指数(BMI)。分析患者行双睾切除术后代谢综合征的风险是否增加。结果患者双睾切除后体重指数、腰围、甘油三脂、空腹血糖明显高于对照组(P<0.01),而血清总睾酮、高密度脂蛋白明显低于对照组(P<0.01),血压、总胆固醇、低密度脂蛋白与对照组比较差异无统计学意义(P>0.05)。结论前列腺癌患者双睾切除后1年以上,代谢综合征的风险明显增加,预示这些患者有更高的心血管疾病风险。 Objective To evaluate the prevalence of metabolic syndrome in men with prostate cancer after bilateral orchidectomy. Methods Total of 100 aged participants were enrolled in this study. Diagnosis criteria of MS was defined by modified the National Cholesterol Education Program-Adult Treatment Panel Ⅲ(NCEP-ATP Ⅲ). Experimental group was fifty men who received bilateral orchidectomy because of prostate cancer, control group was fifty age-matched men of Shanghai Men's Health Club. Height, weight, waist circumference, blood pressure, fasting blood glucose,fasting lipid, total serum testosterone and body mass index(BMI) were measured in all participants. We then analyzed if men who received bilateral orchidectomy because of prostate cancer had more hazard to control. Results Mean age was similar between the two groups. Men who received bilateral orchidectomy because of prostate cancer had high score in body mass index(BMI), waist circumference, triglyceride(TG) and fasting blood glucose in contrast with that of control group (P〈0.01), but their total serum testosterone and high density lipoprotein(HDL) were significantly lower than that. of control group (P〈0.01). There were no significant differences in blood pressure, cholesterol, low density lipoprotein (LDL) between two groups (P〉0.05). Conclusion One year later, patients who underwent bilateral orchidectomy had more hazard to have metabolic syndrome, which indicates that they will have higher cardiovascular risk. Prospective studies on this association merit to be further investigated.
出处 《中国男科学杂志》 CAS CSCD 2010年第4期36-38,42,共4页 Chinese Journal of Andrology
关键词 前列腺肿瘤 睾丸切除术 代谢综合征 prostatic neoplasms orchiectomy metabolic syndrome
  • 相关文献

参考文献17

  • 1Heidenreich A,Aus G,Bolla M,et al.EAU guidelines on prostate cancer.Actas Urol Esp 2009;33(2):113-126.
  • 2Laaksonen DE,Niskanen L,Punnonen K,et al.Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.Diabetes Care 2004; 27(5):1036-1041.
  • 3Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP)Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel Ⅲ).JAMA 2001; 285(19):2486-2497.
  • 4Tan CE,Ma S,Wai D,et al.Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27(5):1182-1186.
  • 5Huggins C.Effect of orchiectomy and irradiation on cancer of the prostate.Ann Surg 1942; 115(6):1192-1200.
  • 6Loblaw DA,Virgo KS,Nam R,et al.Initial hormonal management of androgen-sensitive metastatic,recurrent,or progressive prostate cancer:2006 update of an American Society of Clinical Oncology practice guideline.J Clin Oncol 2007; 25(12):1596-1605.
  • 7Reaven GM.Banting Lecture.1988.Role of insulin resistance in human disease.Diabetes 1988; 37(12):1595-1607.
  • 8Definition,Diagnosis and Classiication of Diabetes Mellitus and Its Complications:report of a WHO consultation.Geneva,Switzerland:Department of Noncommunicable Disease Surveillance.World Health Organization,1999.
  • 9Muller M,Grobbee DE,den Tonkelaar I,et al.Endogenous sex hormones and metabolic syndrome in aging men.J Clin Endocrinol Metab 2005; 90(5):2618-2623.
  • 10Laaksonen DE,Niskanen L,Punnonen K,et al.Sex hormones,inflammation and the metabolic syndrome:a population-based study.Eur J Endocrinol 2003; 149 (16):601-608.

二级参考文献2

共引文献579

同被引文献27

  • 1王荫槐,赵晓昆,杨罗艳,张选志,刘任.前列腺癌去雄激素治疗不良反应的预防和处理[J].中国男科学杂志,2006,20(8):36-38. 被引量:4
  • 2高天,姚玉婷,蔡华杰,沈莉蕴.老年男性血清睾酮对代谢综合征各组分的影响[J].中国男科学杂志,2007,21(7):46-50. 被引量:3
  • 3Greenspan SL, Coates P, Sereika SM, et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005, 90 (12): 6410-6417.
  • 4Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Uro12011, 59(1): 61-71.
  • 5Torimoto K, Samma S, Kagebayashi Y, et al. The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer. Jpn J Clin Oncol 2011, 41(4): 577-581.
  • 6Hara N, Nishiyama T, Takizawa I, et al. Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. Urology 2010, 75(6): 1441-1445.
  • 7Beer TM, Tangen CM, Bland LB, et al. The prognostic value of hemoglobin change after initiating androgen- deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894. Cancer 2006, 107(3): 489-496.
  • 8Shahani S, Braga-Basaria M, Maggio M, et al. Androgens and erythropoiesis:past and present. JEndocrinol Invest 2009, 32(8): 704-716.
  • 9Bachman E, Feng R, Travison T, et al. Testosteronesuppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010, 95(10): 4743-4747.
  • 10Smith MR, Finkelstein JS, McGovern F J, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002, 87(2): 599-603.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部